FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131291214> ?p ?o ?g. }

• W2131291214 endingPage "682" @default.
• W2131291214 startingPage "674" @default.
• W2131291214 abstract "PURPOSE: To assess retrospectively the interim results and the complications of ethanol embolization treatment of arteriovenous malformations (AVMs). MATERIALS AND METHODS: Institutional review board approval was obtained for a retrospective review of patient medical and imaging records. Informed consent was not required by the institutional review board. Written consent for the procedure was obtained from all patients after a discussion about the advantages and risks of the procedure. After a general anesthetic was administered, 40 patients (16 male, 24 female; age range, 9–53 years) with inoperable AVMs in the body and extremities underwent staged ethanol embolizations (range, 1–24; median, 3). Pulmonary artery pressure and arterial blood pressure were monitored as ethanol was injected. Ethanol embolizations (50%–100% ethanol mixed with nonionic contrast material) were performed by using transcatheter and/or direct puncture techniques. Ten patients underwent additional coil deployment during ethanol embolization. Clinical follow-up (range, 2–48 months; mean, 14.6 months; median, 12 months) was performed in all patients, and results from imaging follow-up (range, 0–48 months; mean, 8.4 months; median, 6 months) were available from the last treatment session in 28 patients. Therapeutic outcomes were established by evaluating the clinical outcome of symptoms and signs, as well as the degree of devascularization at follow-up angiography. RESULTS: One hundred seventy-five ethanol embolizations were performed in 40 patients. Sixteen (40%) of 40 patients were cured, 11 (28%) had partial remission, seven (18%) had no remission, and one (2%) experienced aggravation. Treatment failed in five patients (12%). Ethanol embolization was considered effective (cure, 16 patients; partial remission, 11 patients) in 27 patients (68%). Eleven patients will need further treatment sessions for residual AVMs. Twenty-one patients (52%) experienced complications. Twenty-seven minor complications (skin and transient peripheral nerve injuries) (27 [15%] of 175 procedures) occurred in 18 (45%) of 40 patients. All minor complications were healed with wound dressing and observation. Five major complications (five [3%] of 175 procedures) occurred in five (12%) of 40 patients, and four patients recovered completely. CONCLUSION: Ethanol embolization has the potential for cure in the management of AVMs of the body and extremities but with acceptable risk of minor and major complications. © RSNA, 2005" @default.
• W2131291214 created "2016-06-24" @default.
• W2131291214 creator A5009491868 @default.
• W2131291214 creator A5012519000 @default.
• W2131291214 creator A5020441174 @default.
• W2131291214 creator A5021904058 @default.
• W2131291214 creator A5041196001 @default.
• W2131291214 creator A5054627031 @default.
• W2131291214 creator A5063655132 @default.
• W2131291214 creator A5078440382 @default.
• W2131291214 creator A5081038268 @default.
• W2131291214 creator A5087032903 @default.
• W2131291214 date "2005-05-01" @default.
• W2131291214 modified "2023-10-18" @default.
• W2131291214 title "Ethanol Embolization of Arteriovenous Malformations: Interim Results" @default.
• W2131291214 cites W1570985793 @default.
• W2131291214 cites W1963743304 @default.
• W2131291214 cites W1971023541 @default.
• W2131291214 cites W1981547624 @default.
• W2131291214 cites W1990427030 @default.
• W2131291214 cites W1994700997 @default.
• W2131291214 cites W2005953656 @default.
• W2131291214 cites W2006149251 @default.
• W2131291214 cites W2015199038 @default.
• W2131291214 cites W2016991847 @default.
• W2131291214 cites W2032820727 @default.
• W2131291214 cites W2049195965 @default.
• W2131291214 cites W2052346207 @default.
• W2131291214 cites W2087925667 @default.
• W2131291214 cites W2093257744 @default.
• W2131291214 cites W2111932716 @default.
• W2131291214 cites W2131528104 @default.
• W2131291214 cites W2141175498 @default.
• W2131291214 cites W2168360127 @default.
• W2131291214 cites W2294090547 @default.
• W2131291214 cites W2334024869 @default.
• W2131291214 cites W4230285208 @default.
• W2131291214 doi "https://doi.org/10.1148/radiol.2352040449" @default.
• W2131291214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15858106" @default.
• W2131291214 hasPublicationYear "2005" @default.
• W2131291214 type Work @default.
• W2131291214 sameAs 2131291214 @default.
• W2131291214 citedByCount "208" @default.
• W2131291214 countsByYear W21312912142012 @default.
• W2131291214 countsByYear W21312912142013 @default.
• W2131291214 countsByYear W21312912142014 @default.
• W2131291214 countsByYear W21312912142015 @default.
• W2131291214 countsByYear W21312912142016 @default.
• W2131291214 countsByYear W21312912142017 @default.
• W2131291214 countsByYear W21312912142018 @default.
• W2131291214 countsByYear W21312912142019 @default.
• W2131291214 countsByYear W21312912142020 @default.
• W2131291214 countsByYear W21312912142021 @default.
• W2131291214 countsByYear W21312912142022 @default.
• W2131291214 countsByYear W21312912142023 @default.
• W2131291214 crossrefType "journal-article" @default.
• W2131291214 hasAuthorship W2131291214A5009491868 @default.
• W2131291214 hasAuthorship W2131291214A5012519000 @default.
• W2131291214 hasAuthorship W2131291214A5020441174 @default.
• W2131291214 hasAuthorship W2131291214A5021904058 @default.
• W2131291214 hasAuthorship W2131291214A5041196001 @default.
• W2131291214 hasAuthorship W2131291214A5054627031 @default.
• W2131291214 hasAuthorship W2131291214A5063655132 @default.
• W2131291214 hasAuthorship W2131291214A5078440382 @default.
• W2131291214 hasAuthorship W2131291214A5081038268 @default.
• W2131291214 hasAuthorship W2131291214A5087032903 @default.
• W2131291214 hasConcept C126322002 @default.
• W2131291214 hasConcept C126838900 @default.
• W2131291214 hasConcept C141071460 @default.
• W2131291214 hasConcept C167135981 @default.
• W2131291214 hasConcept C168563851 @default.
• W2131291214 hasConcept C195910791 @default.
• W2131291214 hasConcept C2776035437 @default.
• W2131291214 hasConcept C2777106319 @default.
• W2131291214 hasConcept C2778620186 @default.
• W2131291214 hasConcept C2780643987 @default.
• W2131291214 hasConcept C535046627 @default.
• W2131291214 hasConcept C61943457 @default.
• W2131291214 hasConcept C71924100 @default.
• W2131291214 hasConceptScore W2131291214C126322002 @default.
• W2131291214 hasConceptScore W2131291214C126838900 @default.
• W2131291214 hasConceptScore W2131291214C141071460 @default.
• W2131291214 hasConceptScore W2131291214C167135981 @default.
• W2131291214 hasConceptScore W2131291214C168563851 @default.
• W2131291214 hasConceptScore W2131291214C195910791 @default.
• W2131291214 hasConceptScore W2131291214C2776035437 @default.
• W2131291214 hasConceptScore W2131291214C2777106319 @default.
• W2131291214 hasConceptScore W2131291214C2778620186 @default.
• W2131291214 hasConceptScore W2131291214C2780643987 @default.
• W2131291214 hasConceptScore W2131291214C535046627 @default.
• W2131291214 hasConceptScore W2131291214C61943457 @default.
• W2131291214 hasConceptScore W2131291214C71924100 @default.
• W2131291214 hasIssue "2" @default.
• W2131291214 hasLocation W21312912141 @default.
• W2131291214 hasLocation W21312912142 @default.
• W2131291214 hasOpenAccess W2131291214 @default.
• W2131291214 hasPrimaryLocation W21312912141 @default.
• W2131291214 hasRelatedWork W2044945895 @default.

• next